COVID-19 Resources

RCPath advice on histopathology frozen sections and cytology FNA during infectious disease outbreaks

RCPath article - cytology and the pandemic (July 2020)

RCPath advice on the opening of fresh or unfixed histopathological specimens during infectious disease outbreaks

COVID-19 - recommendations for laboratory work (IBMS, RCPath, ACP and ACB 29th March 2020)

Impact of the COVID-19 pandemic on cytology practice: An international survey in the Asia-Pacific region

Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID?19) infection: Perspectives from Taiwan 

Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS?CoV?2: An italian institutional experience focusing on biosafety procedures 

The COVID-19 pandemic: Implications for the cytology laboratory The Journal of American Society for Cytopathology

Coronavirus disinfection in histopathology

RCPath Briefing on Testing for COVID-19

RCPath guidance for remote digital pathology

AAPT RCPath advice Guidance for care of deceased during COVID-19 pandemic

RCPath advice on multidisciplinary team meetings during infectious disease outbreaks

PHE COVID-19: safe handling and processing for samples in laboratories

Guidance on infection prevention and control for COVID-19

NHS Guidance on Coronavirus

© 2021 British Association for Cytopathology
Development by Artonezero
BAC Office  ·  12 Coldbath Square, London EC1R 5HL  ·  Tel: +44 (0) 20 7278 6907  ·  Email: mail@britishcytology.org.uk  ·  Registered Charity 276829

@britishcytology

We use strictly necessary cookies to improve your experience of our site. These are cookies that are required for the operation of our websites. If you continue to use this website, we will assume your consent. See our cookie policy for further information.